Skip to main content
Premium Trial:

Request an Annual Quote

Shimadzu, NEC, National Center for Biotechnology Information, Susan Clark, Doug Rau, Agostino Fede

Premium

New Products

Shimadzu and NEC launched this week a proteomics analysis data management software called SOLPHI. The software tests data for protein analysis based on two-dimensional electrophoresis. It is based on NEC's proprietary protein analysis support system BioPrism.

The SOLPHI software for up to 10 users sells for $26,000. NEC is in charge of support, while Shimadzu handles sales.


The National Center for Biotechnology Information has released RefSeq 13 at ftp://ftp.ncbi.nih.gov/refseq/release/. The release includes 1,899,454 proteins and sequences from 3,060 different organisms.

 

Movers & Shakers

Susan Clark joined Dynex Technologies as vice president of sales and marketing, Dynex's parent company, Magellan Biosciences, said this week.

Clark previously served as sales manager for Thermo Electron's trace chemical analysis group, part of its scientific instrument division.

Clark holds a BS in biology from the University of Akron in Ohio.


Sigma-Aldrich has named Doug Rau as its vice president of human resources, Sigma-Aldrich said this week.

Rau most recently served as vice president of human resources at Kellwood, an apparel company. He also served as Kellwood's director of training and development for five years.

Rau holds an MBA degree from Saint Louis University and a BA in business administration from the University of Missouri, Columbia.


Agostino Fede has been appointed senior vice president of global central labs of PPD and will take the position next March, the company said last week.

PPD recently changed its name from Medical Research Laboratories International.

Fede most recently served as chief executive officer and founder of Vizyo, a drug development informatics venture in Geneva, and previously served as vice president of operations and sales director for Covance Central Laboratories in Europe.

He has also held management positions with CR Bard and the diagnostics division of Abbott Laboratories.

Fede holds an MS and PhD in molecular biology and biophysics from the Swiss Federal Institute of Technology and also earned an MBA from Ashridge Business School in the UK.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.